| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |